1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Afatinib Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 30mg Tables 1.2.3 40mg Tables 1.2.4 50mg Tables 1.2.5 25mg Tables 1.2.6 20mg Tables 1.2.7 Other 1.3 Market by Application 1.3.1 Global Afatinib Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Drug Center 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Afatinib Market Perspective (2016-2027) 2.2 Afatinib Growth Trends by Regions 2.2.1 Afatinib Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Afatinib Historic Market Share by Regions (2016-2021) 2.2.3 Afatinib Forecasted Market Size by Regions (2022-2027) 2.3 Afatinib Industry Dynamic 2.3.1 Afatinib Market Trends 2.3.2 Afatinib Market Drivers 2.3.3 Afatinib Market Challenges 2.3.4 Afatinib Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Afatinib Players by Revenue 3.1.1 Global Top Afatinib Players by Revenue (2016-2021) 3.1.2 Global Afatinib Revenue Market Share by Players (2016-2021) 3.2 Global Afatinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Afatinib Revenue 3.4 Global Afatinib Market Concentration Ratio 3.4.1 Global Afatinib Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Afatinib Revenue in 2020 3.5 Afatinib Key Players Head office and Area Served 3.6 Key Players Afatinib Product Solution and Service 3.7 Date of Enter into Afatinib Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Afatinib Breakdown Data by Type 4.1 Global Afatinib Historic Market Size by Type (2016-2021) 4.2 Global Afatinib Forecasted Market Size by Type (2022-2027) 5 Afatinib Breakdown Data by Application 5.1 Global Afatinib Historic Market Size by Application (2016-2021) 5.2 Global Afatinib Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Afatinib Market Size (2016-2027) 6.2 North America Afatinib Market Size by Type 6.2.1 North America Afatinib Market Size by Type (2016-2021) 6.2.2 North America Afatinib Market Size by Type (2022-2027) 6.2.3 North America Afatinib Market Size by Type (2016-2027) 6.3 North America Afatinib Market Size by Application 6.3.1 North America Afatinib Market Size by Application (2016-2021) 6.3.2 North America Afatinib Market Size by Application (2022-2027) 6.3.3 North America Afatinib Market Size by Application (2016-2027) 6.4 North America Afatinib Market Size by Country 6.4.1 North America Afatinib Market Size by Country (2016-2021) 6.4.2 North America Afatinib Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Afatinib Market Size (2016-2027) 7.2 Europe Afatinib Market Size by Type 7.2.1 Europe Afatinib Market Size by Type (2016-2021) 7.2.2 Europe Afatinib Market Size by Type (2022-2027) 7.2.3 Europe Afatinib Market Size by Type (2016-2027) 7.3 Europe Afatinib Market Size by Application 7.3.1 Europe Afatinib Market Size by Application (2016-2021) 7.3.2 Europe Afatinib Market Size by Application (2022-2027) 7.3.3 Europe Afatinib Market Size by Application (2016-2027) 7.4 Europe Afatinib Market Size by Country 7.4.1 Europe Afatinib Market Size by Country (2016-2021) 7.4.2 Europe Afatinib Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Afatinib Market Size (2016-2027) 8.2 Asia-Pacific Afatinib Market Size by Type 8.2.1 Asia-Pacific Afatinib Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Afatinib Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Afatinib Market Size by Type (2016-2027) 8.3 Asia-Pacific Afatinib Market Size by Application 8.3.1 Asia-Pacific Afatinib Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Afatinib Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Afatinib Market Size by Application (2016-2027) 8.4 Asia-Pacific Afatinib Market Size by Region 8.4.1 Asia-Pacific Afatinib Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Afatinib Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Afatinib Market Size (2016-2027) 9.2 Latin America Afatinib Market Size by Type 9.2.1 Latin America Afatinib Market Size by Type (2016-2021) 9.2.2 Latin America Afatinib Market Size by Type (2022-2027) 9.2.3 Latin America Afatinib Market Size by Type (2016-2027) 9.3 Latin America Afatinib Market Size by Application 9.3.1 Latin America Afatinib Market Size by Application (2016-2021) 9.3.2 Latin America Afatinib Market Size by Application (2022-2027) 9.3.3 Latin America Afatinib Market Size by Application (2016-2027) 9.4 Latin America Afatinib Market Size by Country 9.4.1 Latin America Afatinib Market Size by Country (2016-2021) 9.4.2 Latin America Afatinib Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Afatinib Market Size (2016-2027) 10.2 Middle East & Africa Afatinib Market Size by Type 10.2.1 Middle East & Africa Afatinib Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Afatinib Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Afatinib Market Size by Type (2016-2027) 10.3 Middle East & Africa Afatinib Market Size by Application 10.3.1 Middle East & Africa Afatinib Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Afatinib Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Afatinib Market Size by Application (2016-2027) 10.4 Middle East & Africa Afatinib Market Size by Country 10.4.1 Middle East & Africa Afatinib Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Afatinib Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Boehringer Ingelheim 11.1.1 Boehringer Ingelheim Company Details 11.1.2 Boehringer Ingelheim Business Overview 11.1.3 Boehringer Ingelheim Afatinib Introduction 11.1.4 Boehringer Ingelheim Revenue in Afatinib Business (2016-2021) 11.1.5 Boehringer Ingelheim Recent Development 11.2 Hengrui Medicine 11.2.1 Hengrui Medicine Company Details 11.2.2 Hengrui Medicine Business Overview 11.2.3 Hengrui Medicine Afatinib Introduction 11.2.4 Hengrui Medicine Revenue in Afatinib Business (2016-2021) 11.2.5 Hengrui Medicine Recent Development 11.3 Beacon Pharma 11.3.1 Beacon Pharma Company Details 11.3.2 Beacon Pharma Business Overview 11.3.3 Beacon Pharma Afatinib Introduction 11.3.4 Beacon Pharma Revenue in Afatinib Business (2016-2021) 11.3.5 Beacon Pharma Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Afatinib Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of 30mg Tables Table 3. Key Players of 40mg Tables Table 4. Key Players of 50mg Tables Table 5. Key Players of 25mg Tables Table 6. Key Players of 20mg Tables Table 7. Key Players of Other Table 8. Global Afatinib Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Afatinib Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Afatinib Market Size by Regions (2016-2021) & (US$ Million) Table 11. Global Afatinib Market Share by Regions (2016-2021) Table 12. Global Afatinib Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 13. Global Afatinib Market Share by Regions (2022-2027) Table 14. Afatinib Market Trends Table 15. Afatinib Market Drivers Table 16. Afatinib Market Challenges Table 17. Afatinib Market Restraints Table 18. Global Afatinib Revenue by Players (2016-2021) & (US$ Million) Table 19. Global Afatinib Market Share by Players (2016-2021) Table 20. Global Top Afatinib Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Afatinib as of 2020) Table 21. Ranking of Global Top Afatinib Companies by Revenue (US$ Million) in 2020 Table 22. Global 5 Largest Players Market Share by Afatinib Revenue (CR5 and HHI) & (2016-2021) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Afatinib Product Solution and Service Table 25. Date of Enter into Afatinib Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Afatinib Market Size by Type (2016-2021) (US$ Million) Table 28. Global Afatinib Revenue Market Share by Type (2016-2021) Table 29. Global Afatinib Forecasted Market Size by Type (2022-2027) (US$ Million) Table 30. Global Afatinib Revenue Market Share by Type (2022-2027) & (US$ Million) Table 31. Global Afatinib Market Size Share by Application (2016-2021) & (US$ Million) Table 32. Global Afatinib Revenue Market Share by Application (2016-2021) Table 33. Global Afatinib Forecasted Market Size by Application (2022-2027) (US$ Million) Table 34. Global Afatinib Revenue Market Share by Application (2022-2027) & (US$ Million) Table 35. North America Afatinib Market Size by Type (2016-2021) (US$ Million) Table 36. North America Afatinib Market Size by Type (2022-2027) & (US$ Million) Table 37. North America Afatinib Market Size by Application (2016-2021) (US$ Million) Table 38. North America Afatinib Market Size by Application (2022-2027) & (US$ Million) Table 39. North America Afatinib Market Size by Country (2016-2021) & (US$ Million) Table 40. North America Afatinib Market Size by Country (2022-2027) & (US$ Million) Table 41. Europe Afatinib Market Size by Type (2016-2021) (US$ Million) Table 42. Europe Afatinib Market Size by Type (2022-2027) & (US$ Million) Table 43. Europe Afatinib Market Size by Application (2016-2021) (US$ Million) Table 44. Europe Afatinib Market Size by Application (2022-2027) & (US$ Million) Table 45. Europe Afatinib Market Size by Country (2016-2021) & (US$ Million) Table 46. Europe Afatinib Market Size by Country (2022-2027) & (US$ Million) Table 47. Asia-Pacific Afatinib Market Size by Type (2016-2021) (US$ Million) Table 48. Asia-Pacific Afatinib Market Size by Type (2022-2027) & (US$ Million) Table 49. Asia-Pacific Afatinib Market Size by Application (2016-2021) (US$ Million) Table 50. Asia-Pacific Afatinib Market Size by Application (2022-2027) & (US$ Million) Table 51. Asia-Pacific Afatinib Market Size by Region (2016-2021) & (US$ Million) Table 52. Asia-Pacific Afatinib Market Size by Region (2022-2027) & (US$ Million) Table 53. Latin America Afatinib Market Size by Type (2016-2021) (US$ Million) Table 54. Latin America Afatinib Market Size by Type (2022-2027) & (US$ Million) Table 55. Latin America Afatinib Market Size by Application (2016-2021) (US$ Million) Table 56. Latin America Afatinib Market Size by Application (2022-2027) & (US$ Million) Table 57. Latin America Afatinib Market Size by Country (2016-2021) & (US$ Million) Table 58. Latin America Afatinib Market Size by Country (2022-2027) & (US$ Million) Table 59. Middle East & Africa Afatinib Market Size by Type (2016-2021) (US$ Million) Table 60. Middle East & Africa Afatinib Market Size by Type (2022-2027) & (US$ Million) Table 61. Middle East & Africa Afatinib Market Size by Application (2016-2021) (US$ Million) Table 62. Middle East & Africa Afatinib Market Size by Application (2022-2027) & (US$ Million) Table 63. Middle East & Africa Afatinib Market Size by Country (2016-2021) & (US$ Million) Table 64. Middle East & Africa Afatinib Market Size by Country (2022-2027) & (US$ Million) Table 65. Boehringer Ingelheim Company Details Table 66. Boehringer Ingelheim Business Overview Table 67. Boehringer Ingelheim Afatinib Product Table 68. Boehringer Ingelheim Revenue in Afatinib Business (2016-2021) & (US$ Million) Table 69. Boehringer Ingelheim Recent Development Table 70. Hengrui Medicine Company Details Table 71. Hengrui Medicine Business Overview Table 72. Hengrui Medicine Afatinib Product Table 73. Hengrui Medicine Revenue in Afatinib Business (2016-2021) & (US$ Million) Table 74. Hengrui Medicine Recent Development Table 75. Beacon Pharma Company Details Table 76. Beacon Pharma Business Overview Table 77. Beacon Pharma Afatinib Product Table 78. Beacon Pharma Revenue in Afatinib Business (2016-2021) & (US$ Million) Table 79. Beacon Pharma Recent Development Table 80. Research Programs/Design for This Report Table 81. Key Data Information from Secondary Sources Table 82. Key Data Information from Primary Sources List of Figures Figure 1. Global Afatinib Market Share by Type: 2020 VS 2027 Figure 2. 30mg Tables Features Figure 3. 40mg Tables Features Figure 4. 50mg Tables Features Figure 5. 25mg Tables Features Figure 6. 20mg Tables Features Figure 7. Other Features Figure 8. Global Afatinib Market Share by Application: 2020 VS 2027 Figure 9. Hospital Case Studies Figure 10. Clinic Case Studies Figure 11. Drug Center Case Studies Figure 12. Other Case Studies Figure 13. Afatinib Report Years Considered Figure 14. Global Afatinib Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 15. Global Afatinib Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Afatinib Market Share by Regions: 2020 VS 2027 Figure 17. Global Afatinib Market Share by Regions (2022-2027) Figure 18. Global Afatinib Market Share by Players in 2020 Figure 19. Global Top Afatinib Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Afatinib as of 2020 Figure 20. The Top 10 and 5 Players Market Share by Afatinib Revenue in 2020 Figure 21. Global Afatinib Revenue Market Share by Type (2016-2021) Figure 22. Global Afatinib Revenue Market Share by Type (2022-2027) Figure 23. North America Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. North America Afatinib Market Share by Type (2016-2027) Figure 25. North America Afatinib Market Share by Application (2016-2027) Figure 26. North America Afatinib Market Share by Country (2016-2027) Figure 27. United States Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Canada Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Afatinib Market Share by Type (2016-2027) Figure 31. Europe Afatinib Market Share by Application (2016-2027) Figure 32. Europe Afatinib Market Share by Country (2016-2027) Figure 33. Germany Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. France Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. U.K. Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Italy Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Russia Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Nordic Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Afatinib Market Share by Type (2016-2027) Figure 41. Asia-Pacific Afatinib Market Share by Application (2016-2027) Figure 42. Asia-Pacific Afatinib Market Share by Region (2016-2027) Figure 43. China Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Japan Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. South Korea Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Southeast Asia Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. India Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Australia Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Afatinib Market Share by Type (2016-2027) Figure 51. Latin America Afatinib Market Share by Application (2016-2027) Figure 52. Latin America Afatinib Market Share by Country (2016-2027) Figure 53. Mexico Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Brazil Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Afatinib Market Share by Type (2016-2027) Figure 57. Middle East & Africa Afatinib Market Share by Application (2016-2027) Figure 58. Middle East & Africa Afatinib Market Share by Country (2016-2027) Figure 59. Turkey Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Saudi Arabia Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. UAE Afatinib Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Boehringer Ingelheim Revenue Growth Rate in Afatinib Business (2016-2021) Figure 63. Hengrui Medicine Revenue Growth Rate in Afatinib Business (2016-2021) Figure 64. Beacon Pharma Revenue Growth Rate in Afatinib Business (2016-2021) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

Boehringer Ingelheim Hengrui Medicine Beacon Pharma